Activating and Identifying Neural Responses to Social Rejection: a Combined tDCS and fMRI Study
NCT ID: NCT02739789
Last Updated: 2020-07-08
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
19 participants
INTERVENTIONAL
2018-02-14
2018-10-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
MRI-Guided High-Definition Transcranial Direct Current Stimulation (tDCS) for Depression
NCT05090397
Relationship Between Attention and Emotional Regulation Post-Traumatic Brain Injury (TBI)
NCT01681589
Pilot Study of Transcranial Direct Current Stimulation (tDCS)
NCT02746705
A Functional Magnetic Resonance Imaging Investigation of Transcranial Direct Current Stimulation
NCT03623815
Effects of tDCS on Cognitive Control and Emotion Regulation in Depressed Patients
NCT03039387
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Aim 2: To identify neural pathways regulating negative moods during social rejection, using tDCS for activation and fMRI for assessment. Using a cross-over, sham-controlled design similar to previous tDCS+fMRI studies, we will measure the effects of anodal tDCS over the right or left VLPFC on neural activity and negative mood during rejection and neutral conditions. Alternate regions in separate subjects may also be stimulated including the dorsolateral prefrontal cortex, insula, anterior cingulate cortex, pre-supplementary, and supplementary motor area \[all regions may be right or left hemisphere\]. All of these regions have been shown to be involved in emotion regulation.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sham tDCS
tDCS stimulation will be administered over the brain area of interest, but will be shorter in duration than the "active" treatment
Sham tDCS
Sham tDCS
Active tDCS
tDCS stimulation will be administered over the brain area of interest
tDCS
tDCS
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
tDCS
tDCS
Sham tDCS
Sham tDCS
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. No diagnosis on Axis I by Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders IV. No current, or within the past 5 years.
3. Not currently in a romantic relationship
4. Ability to understand and follow instructions and oriented to name, time, and place.
5. No additional neurologic or psychiatric disorders
6. No current use of psychotropic drugs or during past 3 months (except marijuana and alcohol)
7. No current use of marijuana or during past 3 weeks
8. Not currently abusing alcohol
9. No history of alcohol or drug dependence within past 5 years
10. A negative urine pregnancy and toxicology screen. Verbal affirmation will be obtained (i.e., "not pregnant" and "not currently using psychotropic drugs or during the past 3 months") during the Screening Visit (Day 1). Urine screen will be obtained on Days 2 and 3. If subject reports that there is a "possibility that she is pregnant" on Day 1 (Screening Visit) a urine pregnancy screen will be performed on that day.
11. (Women): If stopped or started oral contraceptives recently, at least 60 days on/off oral contraceptives.
Exclusion Criteria
2. Metallic dental implants
3. Metallic objects in the brain/skull
4. Medical device implants
5. Implanted electronic devices
6. History of seizures
7. History of strokes
8. Unexplained loss of consciousness
9. Frequent or severe headaches or neck pain
10. Clinically significant, uncontrolled liver, kidney, cardiac, or pulmonary disease
11. Terminal medical diagnosis consistent with survival \< 1 year
12. Pregnancy; childbirth or miscarriage within 6 months, breastfeeding within 6 months of recruitment
13. Serious mental impairment. Mini mental state exam of \< 23/30
14. Chronic skin disease
15. Previous experience with transcranial direct current stimulation (tDCS)
16. Regular tobacco use or tobacco use within past month
17. If using hormonal birth control, taking progestin-only pills (e.g., Cerazette, Ovrette), or Intrauterine devices (Mirena, Skyla), since progestin-only birth controls are more likely to cause mood swings.
1. Metal anywhere in the body
2. Weight over 250 pounds, or girth size incompatible for scanner bore.
18 Years
25 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Stony Brook University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
David Hsu
Assistant Professor of Psychiatry
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David T Hsu, PhD
Role: PRINCIPAL_INVESTIGATOR
Stony Brook University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Stony Brook University
Stony Brook, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol, Statistical Analysis Plan, and Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SBU Psychiatry Pilot
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.